UDG Healthcare logo

UDG - UDG Healthcare News Story

800.5p 1.5  0.2%

Last Trade - 05/12/19

Mid Cap
Market Cap £2.00bn
Enterprise Value £2.05bn
Revenue £989.5m
Position in Universe 290th / 1841

UDG Healthcare Plc - Corporate Broker Appointments

Thu 7th November, 2019 7:01am
RNS Number : 5071S
UDG Healthcare Public Limited Co.
07 November 2019


7 November 2019



UDG Healthcare plc


Corporate Broker Appointments


UDG Healthcare, a leading international healthcare services provider, announces it has appointed Liberum and Peel Hunt as joint corporate brokers along with Davy, whom UDG Healthcare retain as joint corporate broker.







For further information, please contact:



Investors and Analysts:

Keith Byrne

SVP, IR, Strategy & Corporate Communications

UDG Healthcare plc

Tel: + 353-1-468-9000




Peel Hunt

James Steel

Tel: +44 20 7418 8900



John Fishley

Tel: +44 (0)20 3100 2000



Ronan Veale

Tel: +353-1-679-7788



Lisa Kavanagh / Jack Hickey

Tel: + 44-207-250-1446




About UDG Healthcare plc


UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing 9,000 people with operations in 26 countries and delivering services in over 50 countries.


UDG Healthcare plc operates across two divisions: Ashfield and Sharp.


Ashfield - Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across three broad areas of activity: advisory, communications and commercial & clinical services. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.


Sharp - Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state-of-the-art facilities in the US and Europe. 


The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.


For more information, please go to: www.udghealthcare.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.